DevCurationThe Premier Voice of the Entire Tech Ecosystem
Home
Where the Money Moved
News
Events
Investor Spotlight
Company Spotlight
Frameworks
DevCuration
Home
Where the Money Moved
News
Events
Investor Spotlight
Company Spotlight
Frameworks
DevCuration
Latest
Ridero's $2.7M Total Backs Vehicle Finance Infrastructure|Dechra Agrees to Acquire Gallant's Cell-Therapy Platform|Aldaron Closes $884M Fund I for AI Transformation Equity|Vanta Agrees to Acquire Pillar Security for AI Governance|IINO Lines Backs TMV Logistics With Undisclosed Commitment|Snapp Discloses $4.6M for Consumer and Team Sports AI|Astral's $5.5M Total Backs AI Math Tutoring Expansion|Coframe Raises $25M Series A for AI Website Experiments|geniosAI Raises $19.1M Across Seed and Series A Rounds|Project Omega Raises $80M to Build Nuclear Fuel Refineries|Ridero's $2.7M Total Backs Vehicle Finance Infrastructure|Dechra Agrees to Acquire Gallant's Cell-Therapy Platform|Aldaron Closes $884M Fund I for AI Transformation Equity|Vanta Agrees to Acquire Pillar Security for AI Governance|IINO Lines Backs TMV Logistics With Undisclosed Commitment|Snapp Discloses $4.6M for Consumer and Team Sports AI|Astral's $5.5M Total Backs AI Math Tutoring Expansion|Coframe Raises $25M Series A for AI Website Experiments|geniosAI Raises $19.1M Across Seed and Series A Rounds|Project Omega Raises $80M to Build Nuclear Fuel Refineries
DevCuration

The premier voice of the tech ecosystem, from ideation to enterprise.

Explore

  • Where the Money Moved
  • Events
  • Articles & Analysis

Spotlights

  • Investor Spotlight
  • Company Spotlight
  • Frameworks

Company

  • About Us
  • Privacy Policy
  • Terms of Service
© 2026 DevCuration. All rights reserved.
TwitterLinkedIn
Logos provided by Logo.dev
Radiopharmaceutical Biotechnology · Company Spotlight

Radiopharmaceutical Biotechnology · Company Spotlight

In-depth spotlights on standout Radiopharmaceutical Biotechnology startups and tech companies.

MTTI Builds an Albumin-Binding Radiopharmaceutical Platform
Company Spotlight

MTTI Builds an Albumin-Binding Radiopharmaceutical Platform

MTTI is building EvaThera, an albumin-binding radiopharmaceutical platform spanning neuroendocrine tumors, lung cancer, thyroid cancer, and imaging tools.

Jesse LandrySep 22, 2026